Endometrial Cancer Clinical Trials in Kunming, Yunnan
4 recruitingKunming, Yunnan, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Merck Sharp & Dohme LLC1,123 enrolled232 locationsNCT06952504
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
Advanced NSCLCAdvanced Endometrial Cancer
Huabo Biopharm Co., Ltd.282 enrolled14 locationsNCT06758557
Recruiting
Phase 3
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
Advanced Endometrial Cancer
Hutchmed412 enrolled17 locationsNCT06584032
Recruiting
Phase 2
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Ovarian CancerEndometrial CancerPrimary Peritoneal Cancer+1 more
Hansoh BioMedical R&D Company460 enrolled28 locationsNCT06014190